维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Duffull SB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal 显示文摘	Page CB Duffull SB Whyte IM	2009	QJM2009，102，2：	1
2	Estimation of pharmacokinetic parameters from non - compartmental variables using Microsoft Excel显示文摘	Dansirikul C Choi M Duffull SB	2005	Comput Biol Med2005，35，5：	1
3	Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations显示文摘	Barras MA Duffull SB Atherton J J	2010	Ther Drug Monit2010，32，4：	1
4	Failure of antivenem to improve recovery in Australian snakebite coagulopathy 显示文摘	Isbister GK Duffull SB Brown SGA	2009	Q J Med2009，102，：	1
5	Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model显示文摘	Duffull SB Begg EJ Chambers ST	1994	Antimicrob Agents Chemother1994，38，10：	1
6	Failure of antivenom to improve recovery in Australian snakebite coagulopathy 显示文摘	Isbister GK Duffull SB Brown SG	2009	QJM2009，2，8：	1
7	Clinical pharmacokinetics and dose optimization of carboplatin显示文摘	Duffull SB Robinson BA	1997	Clin Pharmacokinet1997，33，2：	1
8	Individualized compared with conventional dosing of enoxaparin显示文摘	Barras MA Duffull SB Atherton JJ	2008	Clin Pharmacol Ther2008，83，6：	1
9	Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers显示文摘	Duffull SB Aarons L	2000	Euro J Pharmaceu Sei2000，10，4：	1
10	Application of pharmacokineticpharmacodynamic modelling in management of QT abnormalities after citalopram overdose 显示文摘	Isbister GK Friberg LE Duffull SB	2006	Intensive Care Med2006，32，7：	1
11	Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses 显示文摘	Friberg LE Isbister GK Duffull SB	2006	Br J Clin Pharmacol2006，61，2：	1
12	A pharmacokinetic simulation model for ivabradine in healthy volunteers显示文摘	Duffull SB Chabaud S Nony P	2000	Eur J Pharm Sci2000，10，：	1
13	Compari- son of intraeellular methotrexate kinetics in red blood cells with the kinetics in other cell types显示文摘	Korell J Duffull SB Dalrymple JM	2014	Br J Clin Pharmacol2014，77，3：	1
14	Prospective evaluation of a D-optimal designed population pharmacokinetic study显示文摘	Green B Duffull SB	2003	J Pharmacokinet Pharmacodyn2003，30，2：	1
15	A pharmacokinetic simulation model for ivabradine in healthy volunteers显示文摘	Duffull SB Chabaud S Nony P	2000	Eur J Pharm Sci2000，10，4：	1
16	Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose显示文摘	Duffull SB Isbister GK	2013	Clin Toxicol(Phila)2013，51，8：	1
17	Quantification of lean bodyweight 显示文摘	Janmahasatian S Duffull SB Ash S	2005	Clin Pharmacokinet2005，44，：	1
18	A pharmacoki- netic simulation model for ivabradine in healthy volunteers 显示文摘	DUFFULL SB CHABAUD S NONY P	2000	Eur J Pharm Sci2000，10，4：	1
19	Quantifica-tion of lean bodyweight显示文摘	JANMAHASATIAN S DUFFULL SB ASH S	2005	Clin Pharmacokinet2005，44，10：	1
20	What is the best size descriptor to use for pharmacokinetic studies in the obese? 显示文摘	GREEN B DUFFULL SB	2004	Br J Clin Pharmacol2004，58，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示